Navigation Links
Scientists Show Stem Cells Don't Cause Cancer
Date:2/14/2008

Solving this problem is an important step before moving on to potential therapies

THURSDAY, Feb. 14 (HealthDay News) -- A major concern with using stem cells to treat disease has been the possibility that the retrovirus used to implant the cells might cause cancer, but now a group of scientists appears to have solved that problem.

In November, two groups of researchers -- one in Japan and one in the United States -- showed that adult human and mouse skin cells could be reprogrammed into stem cells similar to embryonic stem cells, which can be made into any type of cell. These cells, called induced pluripotent stem cells (iPS), could be the key to using stem cells to cure a variety of diseases.

In this latest study, published in the Feb. 14 issue of Science, the Japanese researchers prove these stem cells are made from normal mature adult cells, and they show that these stem cells can be implanted using a retrovirus without fear of causing cancer.

"This is a real nice follow-up and confirmation of the previous papers that looked at inducing normal cells to become stem cells," said Dr. Hugh Taylor, an associate professor at Yale University School of Medicine.

"The question that still existed from the previous paper was whether these stem cells were some sort of adult stem cells," Taylor said. "This paper shows that these stem cells are fully differentiated adult cells, that they can be reprogrammed into stem cells," he added. "You can probably take almost any adult cell and turn it into a stem cell."

In addition, there has been a fear that using a retrovirus to implant stem cells results in an increased risk of cancer. This study showed that doesn't happen, Taylor said. "It proves, without a doubt, that these cells are safe for human use," he noted.

However, Taylor thinks the cells need to be studied over a longer period to ensure they don't have an elevated cancer risk.

"It will still take years of basic research before we become able to use iPS cells to treat patients," said lead researcher Dr. Shinya Yamanaka, from Kyoto University in Japan. "We are doing our best to bring it to clinics as quick as possible."

In experiments with mice, Yamanaka's team reprogrammed adult mouse liver and stomach lining cells into iPS cells. Using a retrovirus, the scientists were able to transplant these cells into mice. Moreover, Yamanaka's team found that these reprogrammed cells avoided sites that are known to trigger tumors. In fact, mice that received the iPS remained tumor-free for six months.

Creating embryonic-like stem cells from adult cells may resolve an ethical dilemma, but whether these cells will act like real embryonic stem cells is yet to be determined.

"Using adult cells to create what appeared to be embryonic stem cells solves the ethical dilemma that some people have in creating or destroying embryos to create stem cells," Taylor said.

"The one thing we can't say yet is that whether these stem cells generated in this way will have the full potential that embryonic stem cells have," Taylor said. "They probably won't. But exactly where that line will be drawn isn't known. If they do almost everything that embryonic stem cells do, that'll be wonderful. If they don't, we may still need to consider using embryonic stem cells."

Another expert thinks this is an important step forward, but it's going to take a long time before cells generated this way can be used to treat people.

"They're one step closer to solving the problem," said Paul Sanberg, director of the University of South Florida Center for Aging and Brain Repair in Tampa. "Now they're going to have to grow the cells, implant them in animals, and show that they work for diseases," he said. "There's a lot of experiments to do between making these cells and putting them in people."

More information

For more about stem cells, visit the International Society for Stem Cell Research.



SOURCES: Shinya Yamanaka, M.D., Ph.D., Kyoto University, Japan; Paul Sanberg, Ph.D., D.Sc., distinguished professor of neurosurgery, and director, University of South Florida Center for Aging and Brain Repair, Tampa; Hugh Taylor, M.D., associate professor, Yale University School of Medicine, New Haven, Conn.; Feb. 14, 2008, Science


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Microbial cheaters help scientists ID social genes
2. Scientists solve structure of gene regulator that plays key role in cancer
3. VEGF Neutralization Can Damage Brain Vessels, Say Schepens Eye Research Institute Scientists
4. VEGF neutralization can damage brain vessels, say Schepens Eye Research Institute scientists
5. Precious Time - Scientists discover how long heart failure patients can expect to live
6. UCLA stem cell scientists reprogram human skin cells into embryonic stem cells
7. Scientists Reprogram Human Skin Cells Into Embryonic Stem Cells
8. Scientists from Europe, Israel and the US develop robotic rats to aid in rescue missions
9. Childrens Hospital scientists identify possible target for prevention and treatment of pneumonia
10. NIAID scientists identify new cellular receptor for HIV
11. ECNP launches research grant for young scientists
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Scientists Show Stem Cells Don't Cause Cancer
(Date:2/17/2017)... Rancho Palos Verdes, CA (PRWEB) , ... February ... ... well-being, and emotional flow is Dr. Carol Francis' goals for each ... Federation Retreat Conference, Dr. Carol Francis will demonstrate five different brainwave tools which ...
(Date:2/17/2017)... ... February 17, 2017 , ... ... Conference & Exhibition in Orlando, Fla., February 19-23. Visitors to the company’s booth ... most widely used electronic patient signatures solution in healthcare . , Since ...
(Date:2/17/2017)... (PRWEB) , ... February 17, 2017 , ... ... clinical operations executives and focusing on all facets of clinical trial planning and ... management , patient engagement, and more. In addition, attendees stopping by Pharmica’s booth ...
(Date:2/17/2017)... Atlanta, GA (PRWEB) , ... February 17, 2017 , ... ... ways to reduce readmissions. Driven in large part by the Hospital Readmission Reduction Program ... has been a key focus area for hospitals across the nation. While many providers ...
(Date:2/17/2017)... ... 17, 2017 , ... Dillon Ruxton Insurance, a Florida-based agency ... in the greater Fort Lauderdale metropolitan region, is embarking on a cooperative food ... years, LifeNet 4 Families has provided a broad range of food provision services ...
Breaking Medicine News(10 mins):
(Date:2/16/2017)... 16, 2017  AcelRx Pharmaceuticals, Inc. (Nasdaq: ... on the development and commercialization of innovative therapies ... that Vincent J. Angotti has been ... the company,s board of directors, effective Monday, March ... of experience leading executive and commercial teams at ...
(Date:2/16/2017)... , Feb. 16, 2017  Prescription pain medications ... department visit are necessary for long-term opioid use to ... Feb. 16 th edition of The New ... "Emergency physicians see more patients in acute pain than ... Parker , MD, FACEP, president of the American College ...
(Date:2/16/2017)... , Feb 16, 2017 Research and ... Cancer Diagnostics Market Analysis & Trends - Function, Application, Cancer Type, ... ... Generation Cancer Diagnostics Market is poised to grow at a CAGR ... million by 2025. Some of the prominent ...
Breaking Medicine Technology: